Ventricular Tachycardia Ablation Guidance Includes Randomized Studies

Randomized clinical studies remain an option for sponsors seeking approval of ablation devices for the treatment of ventricular tachycardia (VT), FDA's Center for Devices and Radiological Health says in a recent guidance.